Indirect Calorimetry Guided Energy Provision in Critically Ill Patients With Obesity

NCT ID: NCT06053216

Last Updated: 2025-07-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-02

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The DIRECT trial is a prospective, multi-centre, two arm parallel feasibility pilot randomised controlled trial. The primary aim is to determine the feasibility of using repeat indirect calorimetry measurements to direct energy delivery in critically ill patients with obesity.

The trial will recruit 60 mechanically ventilated patients from 4-6 ICUs in Australia and New Zealand.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Indirect calorimetry is the current reference standard for measuring energy expenditure during critical illness, allowing for personalisation of energy delivery. Use of indirect calorimetry may be important in mitigating under- and overfeeding and associated adverse outcomes. This may be particularly important in patients with obesity, where energy expenditure is difficult to estimate, and limited data is available on the optimal nutritional management of this subgroup.

Although access to indirect calorimetry is gradually improving, it remains an underutilised tool and skills required to complete and interpret measurements are limited which may hinder use and integration into practice. There is a resulting knowledge gap on the impact of indirect calorimetry on outcomes in comparison to standard care predictive equations.

A definitive and pragmatic trial is needed to assess the impact of guiding energy delivery with indirect calorimetry on patient outcomes. Importantly, confirming the feasibility of using indirect calorimetry to guide energy delivery is needed to define optimal measurement protocols prior to completion of a larger trial.

The primary aim of the DIRECT trial is to determine the feasibility of using repeat indirect calorimetry measurements to direct energy delivery in critically ill patients with obesity. The secondary aim is to inform a larger trial by collecting process, nutrition, functional, clinical and safety outcomes.

The investigators will consider the main trial feasible to conduct if 2 of the following 3 feasibility criteria are achieved: (a) recruitment rate is ≥ 1 patient per calendar month; (b) between group separation of ≥20% in energy adequacy during ICU admission is achieved in relation to measured energy expenditure and; (c) the number of indirect calorimetry measurements completed/planned ≥60% during ICU admission.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A multi-centre, prospective, two arm parallel feasibility pilot randomised controlled trial
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Open-label trial. However, clinicians will be blinded to indirect calorimetry measurements in the control arm.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Individualised energy delivery

Energy delivery will be guided by indirect calorimetry, with the aim to meet 80-100% of the most recent energy expenditure measurement from day 4 to 28 of hospital admission.

Group Type EXPERIMENTAL

Indirect calorimetry

Intervention Type OTHER

Weekly indirect calorimetry measurements using the Q-NRG+ device will be used to guide energy delivery up to day 28 of hospital admission.

Standard care nutrition

Energy delivery will be according to predictive equation estimates and usual site practice from day 4 to 28 of hospital admission.

Group Type ACTIVE_COMPARATOR

Indirect calorimetry (Standard care nutrition arm)

Intervention Type OTHER

Weekly indirect calorimetry measurements using the Q-NRG+ device will be conducted up to day 28 of hospital admission. In the standard care nutrition arm, clinicians will be blinded to indirect calorimetry measurements.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Indirect calorimetry

Weekly indirect calorimetry measurements using the Q-NRG+ device will be used to guide energy delivery up to day 28 of hospital admission.

Intervention Type OTHER

Indirect calorimetry (Standard care nutrition arm)

Weekly indirect calorimetry measurements using the Q-NRG+ device will be conducted up to day 28 of hospital admission. In the standard care nutrition arm, clinicians will be blinded to indirect calorimetry measurements.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (≥ 18 years) patients
* Body mass index ≥30 kg/m2
* Between day 3 and 6 of index ICU admission
* Receiving invasive mechanical ventilation
* Receiving enteral or parenteral nutrition

Exclusion Criteria

* Receiving extracorporeal membrane oxygenation support
* Major burns (≥20% total body surface area)
* Unable to perform indirect calorimetry within 24 hours of randomisation
* Known pregnancy
* Death is imminent
* Treating clinician believes the study is not in the best interest of the patient
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Australian and New Zealand Intensive Care Research Centre

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Blacktown Hospital

Blacktown, New South Wales, Australia

Site Status RECRUITING

Royal Prince Alfred Hospital

Camperdown, New South Wales, Australia

Site Status RECRUITING

Ballarat Base Hospital, Grampians Health

Ballarat Central, Victoria, Australia

Site Status RECRUITING

The Alfred Hospital

Melbourne, Victoria, Australia

Site Status RECRUITING

Department of Critical Care Medicine, Auckland City Hospital

Auckland, , New Zealand

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Australia New Zealand

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Oana Tatucu

Role: CONTACT

+61 3 9905 6646

Emma Ridley

Role: CONTACT

+61 3 9903 0350

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Barbara Hannah

Role: primary

+61 2 9881 8000

Suzie Ferrie, Dr

Role: primary

Tim Stewart

Role: primary

Oana Tatucu

Role: primary

+61 3 9905 6646

Varsha Asrani

Role: primary

+64 9 367 0000

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ANZIC-RC/OT001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ICU Nutrition Study Bern
NCT00574431 COMPLETED PHASE4